About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Allo-APZ2-EB

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
36	Epidermolysis bullosa	6

36. Epidermolysis bullosa

Clinical trials : 183 / Drugs : 159 - (DrugBank : 51) / Drug target genes : 69 - Drug target pathways : 147

trials per page:

Showing 1 to 6 of 6 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-001009-98-IT (EUCTR)	11/10/2019	10/11/2020	Study to investigate the efficacy and safety of allo-APZ2-EBon wound healing of epidermolysis bullos ...	An interventional, multicenter, single arm, phase I/IIa clinical trial to investigate the efficacy a ...	Recessive dystrophic epidermolysis bullosa (RDEB) MedDRA version: 20.0;Level: PT;Classification code ...	Product Name: allo-APZ2-EB Product Code: [allo-APZ2-EB] Other descriptive name: Allogeneic skin-derive ...	RHEACELL GmbH & Co. KG	NULL	Not Recruiting			Female: yes Male: yes	18	Phase 1	United States;France;Austria;Germany;United Kingdom;Italy
2	EUCTR2018-001009-98-DE (EUCTR)	01/03/2019	03/05/2018	Study to investigate the efficacy and safety of allo-APZ2-EBon wound healing of epidermolysis bullos ...	An interventional, multicenter, single arm, phase I/IIa clinical trial to investigate the efficacy a ...	Recessive dystrophic epidermolysis bullosa (RDEB) MedDRA version: 20.0;Level: PT;Classification code ...	Product Name: allo-APZ2-EB Product Code: allo-APZ2-EB Other descriptive name: Allogeneic skin-derived ...	RHEACELL GmbH & Co. KG	NULL	Not Recruiting			Female: yes Male: yes	16	Phase 1;Phase 2	United States;France;Austria;Germany;United Kingdom;Italy
3	NCT03529877 (ClinicalTrials.gov)	February 16, 2019	24/4/2018	Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa	An Interventional, Multicenter, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy a ...	Recessive Dystrophic Epidermolysis Bullosa	Biological: allo-APZ2-EB	RHEACELL GmbH & Co. KG	FGK Clinical Research GmbH;Granzer Regulatory Consulting & Services;Ticeba GmbH	Completed	0 Years	55 Years	All	16	Phase 1/Phase 2	United States;Austria;France;Germany;United Kingdom;Italy
4	EUCTR2018-001009-98-FR (EUCTR)	07/01/2019	30/10/2018	Study to investigate the efficacy and safety of allo-APZ2-EBon wound healing of epidermolysis bullos ...	An interventional, multicenter, single arm, phase I/IIa clinical trial to investigate the efficacy a ...	Recessive dystrophic epidermolysis bullosa (RDEB) MedDRA version: 20.0;Level: PT;Classification code ...	Product Name: allo-APZ2-EB Product Code: allo-APZ2-EB Other descriptive name: Allogeneic skin-derived ...	RHEACELL GmbH & Co. KG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	18	Phase 1;Phase 2	United States;France;Austria;Germany;United Kingdom
5	EUCTR2018-001009-98-AT (EUCTR)	05/11/2018	24/05/2018	Study to investigate the efficacy and safety of allo-APZ2-EBon wound healing of epidermolysis bullos ...	An interventional, multicenter, single arm, phase I/IIa clinical trial to investigate the efficacy a ...	Recessive dystrophic epidermolysis bullosa (RDEB) MedDRA version: 20.0;Level: PT;Classification code ...	Product Name: allo-APZ2-EB Product Code: allo-APZ2-EB Other descriptive name: Allogeneic skin-derived ...	RHEACELL GmbH & Co. KG	NULL	Not Recruiting			Female: yes Male: yes	16	Phase 1;Phase 2	United States;France;Austria;Germany;United Kingdom;Italy
6	EUCTR2018-001009-98-GB (EUCTR)	18/09/2018	25/10/2018	Study to investigate the efficacy and safety of allo-APZ2-EBon wound healing of epidermolysis bullos ...	An interventional, multicenter, single arm, phase I/IIa clinical trial to investigate the efficacy a ...	Recessive dystrophic epidermolysis bullosa (RDEB) MedDRA version: 20.0;Level: PT;Classification code ...	Product Name: allo-APZ2-EB Product Code: allo-APZ2-EB Other descriptive name: Allogeneic skin-derived ...	RHEACELL GmbH & Co. KG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	16	Phase 1;Phase 2	United States;France;Austria;Germany;Italy;United Kingdom

First Previous1Next Last